Zdrowie i gospodarka · 17/08/2023
Notice; Licensing and Collaboration Opportunity
The National Institute on Aging (NIA) is seeking a licensee and/or collaborator to further develop a technology that targets amyloid forming IAPP and amyloid-beta in treatments of diabetes and Alzheimer's disease.